Epilepsy Trial, Recruiting NCT07592676 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT07592676
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the prospective part of the study – Case Group (younger participants):

  • People with epilepsy or epileptic syndromes, including those with mild intellectual disability (with or without other health conditions), and people diagnosed with tuberous sclerosis complex
  • People with epilepsy who are at least 15 years old at the time of admission to the DH BRIDGE program
  • People with epilepsy who are regularly seen at the Fondazione Policlinico Universitario A. Gemelli IRCCS hospital, with records showing at least two previous appointments at the Child Neuropsychiatry Unit
  • A parent, legal guardian, or the patient themselves (if legally an adult) must have signed a consent form agreeing to take part
  • If the participant is a minor, they must also sign an assent form agreeing to take part

For the prospective part of the study – Control Group (adult participants):

  • People with epilepsy or epileptic syndromes, including those with mild intellectual disability (with or without other health conditions), and people diagnosed with tuberous sclerosis complex
  • People with epilepsy who are at least 18 years old at their first visit to the Adult Neurology Outpatient Clinic
  • People with epilepsy who are regularly seen at the Fondazione Policlinico Universitario A. Gemelli IRCCS hospital, with records showing at least two visits at the Day Hospital for Drug-Resistant Epilepsies
  • The patient themselves must have signed a consent form, or a parent or legal guardian must have done so if the patient is unable to

For the retrospective (past records) part of the study:

  • People with epilepsy or epileptic syndromes, including those with mild intellectual disability (with or without other health conditions), and people diagnosed with tuberous sclerosis complex
  • People with epilepsy who were over 18 years old at their first visit to the Adult Neurology Outpatient Clinic, and who have had at least six months of follow-up care after that visit
  • People with epilepsy who have been regularly seen at the Fondazione Policlinico Universitario A. Gemelli IRCCS hospital, with at least two documented visits recorded there
  • The patient themselves must have signed a consent form, or a parent or legal guardian must have done so if the patient is unable to

Who may not be able to join:

  • People with epilepsy who have not been regularly attended at the Day Hospital for Drug-Resistant Epilepsies — meaning those with fewer than two recorded visits there — would not meet the eligibility requirements for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Domenica Immacolata Battaglia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +39 06 3015 5293

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 November 2025
Est. completion
1 December 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Adult Clinic Attendance Rate; Return Rate:

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov